2025 saw a significant statutory change and the long-awaited Supreme Court of Canada hearing of an appeal regarding the patentability of methods of medical treatment. The courts also considered due care in the context of paying maintenance fees, the principle of claim differentiation and the Canadian Patent Office’s assessment of subject-matter patentability.
Our presenters Andrea Berenbaum, Reshika Dhir, Michael Sgro and Iris Ngo will provide an annual summary of key developments in Canadian patent law. It offers a valuable opportunity for legal professionals and others interested in Canadian patent law to gain an overview of developments in 2025.
Watch the replay:
Who should attend:
- in-house counsel
- patent agents and attorneys in private practice
- business owners and entrepreneurs
- technology transfer professionals
Speakers:
- Andrea Berenbaum: With a combined background in chemistry and visual biomedical communication design, Andrea’s practice focuses on chemical, pharmaceutical, and biotechnology patents, and includes the drafting and prosecution of such patents.
- Reshika Dhir: Reshika has over a decade of experience in drafting and prosecuting patent applications across a wide range of technologies. She has helped many clients protect their valuable technologies in fields such as telecommunication, signal processing, medical devices, power electronics, payment processing, wearables, cybersecurity, blockchain, data encryption, artificial intelligence, computer networks, mobile applications and robotics.
- Michael Sgro: With a background in chemistry, Michael’s experience covers the pharmaceutical and chemical patent sectors. He specializes in chemical compositions, small molecules (NCEs), semiconductors, polymers, catalysts and catalytic processes, and manufacturing processes and apparatuses.
- Iris Ngo (Moderator): Iris specializes in Chemistry, Biotechnology, and Biopharmaceutical patent procurement. In completing her master’s thesis, Iris developed strong skills in metabolic and protein engineering as well as metabolite purification and identification, enabling her to understand the technical needs of clients.
Looking for CPD/CLE-eligible learning?
This webinar may be eligible for Continuing Professional Development (CPD) or Continuing Legal Education (CLE) credit, subject to the requirements of your governing body.
- LSO: This program contains 1 hour of Substantive content.
- LSBC: This program contains 1 hour of accredited content.
- Barreau du Québec: This program is eligible up to 1 hour in Québec.
Subscribe to be the first to receive updates on our webinars and other thought leadership content, sent straight to your inbox.
Please note that this webinar is presented in English only, with French captions available during the live session. Presentation slides will be available in both languages after the webinar.